Correlation Engine 2.0
Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

A 29-year-old lady receiving repeated blood transfusions for β thalassemia since childhood, presented with rapidly deteriorating symptoms of night blindness and peripheral visual field loss. She was recently commenced on high-dose intravenous desferrioxamine for reducing the systemic iron overload. Clinical and investigative findings were consistent with desferrioxamine-related pigmentary retinopathy and optic neuropathy. Recovery was partial following cessation of desferrioxamine. This report highlights the ocular side-effects of desferrioxamine mesylate and the need to be vigilant in patients on high doses of desferrioxamine.

Citation

Sumu Simon, Paul A Athanasiov, Rajeev Jain, Grant Raymond, Jagjit S Gilhotra. Desferrioxamine-related ocular toxicity: a case report. Indian journal of ophthalmology. 2012 Jul;60(4):315-7

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 22824603

View Full Text